Company profile for BJ Bioscience

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BJ Bioscience Inc. is a biotechnology company dedicated to the research and development of innovative drugs. It is created by returnees with many years of experience in research and development of innovative drugs and complimentary expertise, including a review expert of National Key Innovative Drug R&D Projects, the National Health Commission of China. Based on its top notch trade secret protected antibody generation and scre...
BJ Bioscience Inc. is a biotechnology company dedicated to the research and development of innovative drugs. It is created by returnees with many years of experience in research and development of innovative drugs and complimentary expertise, including a review expert of National Key Innovative Drug R&D Projects, the National Health Commission of China. Based on its top notch trade secret protected antibody generation and screening technology, BJ Bioscience focuses its R&D in cancer, infectious and autoimmune diseases. Key members of the company's R&D team have many years of experience in research and development and management of antibody.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
15th Floor, Building 4, Health Valley, 1500 Wenyi West Road, Yuhang District, ...
Telephone
Telephone
0571-89188996
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/bj-bioscience-announces-clinical-collaboration-with-msd-to-evaluate-bj-001-in-combination-with-keytruda-pembrolizumab-301782741.html

PR NEWSWIRE
27 Mar 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty